Improving immunotherapy response through the use of designer bacteria.

Griffin, Matthew E; Hang, Howard C

Griffin, Matthew E; Hang, Howard C.

Afiliación

Griffin ME; Department of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037.
Hang HC; Department of Immunology and Microbiology, Scripps Research, La Jolla, CA 92037; Department of Chemistry, Scripps Research, La Jolla, CA 92037. Electronic address: hhang@scripps.edu.

Cancer Cell ; 39(12): 1576-1577, 2021 12 13.

Article en En | MEDLINE | ID: mdl-34906317

Asunto(s)

Inmunoterapia; Neoplasias; Animales; Antígeno B7-H1; Bacterias; Humanos; Factores Inmunológicos; Ratones; Neoplasias/terapia; Microambiente Tumoral

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inmunoterapia / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Humans Idioma: En Revista: Cancer Cell Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google